Møller-Bisgaard, S., Ejbjerg, B., Eshed, I., Hørslev-Petersen, K., Hetland, M., Jurik, A., Thomsen, H., Torfing, T., Stengaard-Pedersen, K., Junker, P., Krogh, N., Lottenburger, T., Ellingsen, T., Andersen, L., Skjødt, H., Svendsen, A., Tarp, U., Hansen, I., Pødenphant, J., Pedersen, J., Lindegaard, H., Hanson, L., Vestergaard, A., Glinatsi, D., & Østergaard, M. (2017). effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA). Scandinavian journal of rheumatology, 46, 335–345. http://access.bl.uk/ark:/81055/vdc_100049674724.0x000001